BIO-001

 

You are invited to take part in a challenge study to investigate whether a novel vaccine can prevent malaria. The study is being run by the Oxford Vaccine Group in partnership with the Department of Biochemistry which is part of the University of Oxford and is funded by PATH.

 

If you are aged 18 to 45 years old, in good health and live in the Oxford area, then you may be eligible to take part in the study. We will provide reimbursement for your time, inconvenience, and travel. The total study participation time is 18-26 (Group 1,3-5) / 18 (Group 2) / 3 (Group 6) months.

  1. Group 1,3,4,5 (malaria vaccine groups)

  2. Group 2 (malaria vaccine and malaria infection group)

  3. Group 6 (malaria infection group)